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202a Monday, March 7, 2011understanding of these assembly pathways is of significant importance for both
development of amyloids as functional nanomaterials, as well the biological
understanding of amyloidosis. Using fluctuation microscopy and imaging, we
have previously demonstrated that the nucleation of Amyloid-ß(16-22) peptide,
the nucleating core of Amyloid-ß, initiates within dense unstructured
peptide aggregates, and elongation proceeds via monomer addition to the active
ends of growing nanostructures (Liang et al, J. Am. Chem. Soc. 2010, 132,
6306-6308). This previous work utilized a Rhodamine-labeled amyloid peptide
(Rh1722), which co-assembles with Amyloid- ß(16-22) without affecting the
morphology of the nanostructures. In order to further investigate the mecha-
nisms of assembly at a molecular level, we are using Fluorescence Lifetime
ImagingMicroscopy (FLIM) to probe the lifetime of Rh1722. Rh1722 is highly
sensitive to the local environment, and thus its fluorescence lifetime serves as
a sensitive indicator of local amyloid environment and inferred structure. Our
initial studies have revealed distinct fluorescence lifetime values within amy-
loid aggregates compared to nanotubes, suggesting that this technique will
allow us to follow details at the molecular level in the nucleation, growth,
and maturation processes. We also have evidence for the existence of nucleat-
ing cores within the unstructured peptide aggregates. These observations and
future studies will further inform our understanding of amyloid nucleation
and growth.
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Self-assembly of unstructured protein/peptide monomers into highly ordered,
misfolded protein aggregates is associated with many neurodegenerative dis-
eases, including Alzheimer’s, Parkinson’s, and type II diabetes. Despite signif-
icant progress on the characterization of atomic details of amyloid-b (Ab)
fibrils, much less is known about the structure and kinetics of Ab intermediate
species during the early stage of aggregation, in particular about Ab interac-
tions with cell membranes, which is more biological relevance for understand-
ing the mechanism of neurotoxicity. But, due to complex nature of cell
membranes and notorious environmental sensitivity of Ab aggregation, the
study of Ab-membrane interactions is particularly challenging, often leading
to inconsistent data and controversial explanations of Ab toxicity.
In this work, we use alternative, molecular-designed self-assembled mono-
layers (SAMs) as a surface template to systematically study Ab structure
and aggregation behaviors on the SAMs using molecular dynamics simulation
and experimental approaches (CD, AFM, SPR, and DLS). Four types of the
SAMs terminated with hydrophobic -CH3, hydrophilic -OH, negatively
charged -COOH, and positively charged -NH2 groups are used to mimic cer-
tain surface chemistry of cell membranes and decouple these surface properties
separately to examine their impacts on modulating Ab structures and kinetics
at early aggregation process. Our results show that: (1) all SAMs significantly
accelerate Ab fibril formation as compared to in bulk solution; (2) hydrophobic
CH3-SAM surface induces more Ab adsorption with the strongest bind-
ing affinity, as compared to other SAMs, indicating that hydrophobic interac-
tions are major driving forces for Ab aggregation; (3) Ab adsorption amount
on the SAMs is strongly depended on Ab aggregated state in solution, i.e.
Ab adsorption is reduced when Ab peptides form a hydrophobic core by
C-terminal residues protected by hydrophilic N-terminals in solution. This
work provides parallel and valuable insights into Ab aggregation on the cell
membranes.
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The 40-43 residue-long beta amyloid peptides aggregate in the extracellular
neuronal space to form amyloid plaques, which contain numerous beta amyloid
fibrils. Biological interest in amyloid fibrils arises from their occurrence in am-
yloid diseases, such as Alzheimer’s disease (AD). The truncated pyroglutamate
beta amyloid (p3-42) and beta amyloid (4-42) peptides are two of the most
dominant isoforms found in excised amyloid material from AD brains.
We investigate the self-seeding and cross-seeding behavior of the different
amyloid beta isoforms, and utilize magic angle spinning NMR techniques
to study the molecular structure of the fibrils formed by the amyloid beta
(p3-42) and (4-42) peptides. The structures of these fibrils are compared to
the available structures of the wild type and mutant beta amyloid (1-40) and
(1-42) fibrils.1104-Pos Board B14
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The amyloid-b (Ab) peptide, a major component of the insoluble plaques asso-
ciated with Alzheimer’s disease, is intrinsically disordered under physiological
conditions. Many polyphenolic compounds disrupt aggregation of Ab in vitro.
Interestingly, these compounds have been shown to interact with other
disordered proteins through hydrophobic and aromatic interactions, as well
as, hydrogen bonding with the peptide backbone. Deep-ultraviolet resonance
Raman (UVRR) studies of Ab (1-42) indicate that the environment of at least
one of the phenylalanine residues is altered upon introduction of the polyphe-
nolic flavonoid myricetin.1105-Pos Board B15
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Amyloid fibrils are filamentous aggregates deposited in extracellular tissue in
various neurodegenerative and protein misfolding disorders. Amyloid ß (Aß)
peptides form self-associating fibrillar structures in Alzheimer’s disease. The
Aß25-35 peptide is thought to represent the biologically active, toxic fragment
of the full-length beta peptide.
We have previously shown that Aß25-35 forms an oriented network on mica by
epitaxial assembly mechanisms that significantly accelerate fibril growth.
Whether the structure of the epitaxially grown fibrils is identical to that of
the fibrils assembled under equilibrium conditions is not known. To explore
these differences, we investigated fibril structure and dynamics with AFM,
force spectroscopic, and fluorescence and absorption spectroscopic methods.
To facilitate fluorescence labeling, we employed a mutant peptide, Aß25-
35_N27C, which was labeled with TMRIA. The nanomechanical behavior of
Aß25-35 fibrils was characterized by the appearance of force staircases which
correspond to the force-driven unzipping and dissociation of protofilaments.
The elementary plateau force was 30 pN for both the epitaxially-grown fibrils
and for the fibrils assembled in solution. The average fibril height was 1-3 nm
for the epitaxially-grown fibrils, whereas fibrils grown in solution were 3-15 nm
thick. Unlike epitaxialy-grown fibrils, the fibrils assembled in solution dis-
played a helical structure with 30-50 nm periodicity. Whereas fibril assembly
in solution occurred on a time scale of hours to days, on mica surface fibrils
appeared within a few minutes. In the absorption spectra of TMRIA-labeled
Aß25-35_N27C, a significant peak at 518 nm corresponding to rhodamine
dimmers appeared rapidly, suggesting that peptide dimerization is a fast pro-
cess, and the rate limiting step of fibril growth lies further along the assembly
pathway.1106-Pos Board B16
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Abstract:
The monomer to oligomer transition initiates the aggregation and pathogenic
transformation of Alzheimer’s Amyloid-b (Ab) peptide. However, the mono-
meric state of this aggregation-prone peptide has remained beyond the reach
of most experimental techniques, and a quantitative understanding of this
transition is yet to emerge. Here we employ single molecule level fluores-
cence tools to characterize the monomeric state and the monomer-
oligomer transition at appropriately low concentrations in buffers mimicking
the cerebrospinal fluid (CSF). Our measurements show the monomer to be
a compact object with a hydrodynamic radius of 0.9 5 0.1 nm, which con-
firms the prediction made by some of the in silico studies. Surprisingly, at
equilibrium, both Ab40 and Ab42 remain predominantly monomeric up to
1.5 mM concentration. This concentration is much higher than their estimated
concentrations in the CSF of either normal or diseased brains. However, we
find that a strong kinetic barrier impedes the dissociation of pre-formed olig-
omers. Since Ab oligomers in the CSF are generally accepted to be the key
agents in Alzheimer’s pathology, our results imply that these are released in
the CSF as pre-formed entities, and their metastability allows them to remain
toxic. We conclude that thermodynamic principles allow the development of
pharmacological agents that can catalytically convert these metastable spe-
cies to non-toxic monomers.
